Long-Acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus

By Vilsbøll Tina   Knop Filip K.  

BioDrugs, Vol. 22, Iss. 4, 2008-01 ,pp. : 251-257

Adis International

Access to resources Recommend Favorite

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus

By Korytkowski M.   Bell D.   Jacobsen C.   Suwannasari R.   FlexPenR Study Team  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2836-2848

Elsevier

Access to resources Recommend Favorite

Iliopsoas abscess in adolescents with type 1 diabetes mellitus

By  

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 638-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Shared Genomics of Type 2 and Gestational Diabetes Mellitus

By Wung Shu-Fen   Lin Pei-Chao  

Annual Review of Nursing Research, Vol. 29, Iss. 1, 2011-12 ,pp. : 227-260

Springer Publishing Company

Access to resources Recommend Favorite

Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide: Potential Applications in Type 2 Diabetes Mellitus

By Meier J.J.  

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 93-102

Adis International

Access to resources Recommend Favorite